HomeCompareGLFN vs MRK

GLFN vs MRK: Dividend Comparison 2026

GLFN yields 666666.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLFN wins by $8.275235618773884e+34M in total portfolio value
10 years
GLFN
GLFN
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full GLFN calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GLFN vs MRK

📍 GLFN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLFNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLFN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLFN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLFN
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GLFN beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLFN + MRK for your $10,000?

GLFN: 50%MRK: 50%
100% MRK50/50100% GLFN
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GLFN
No analyst data
Altman Z
-327.9
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLFN buys
0
MRK buys
0
No recent congressional trades found for GLFN or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLFNMRK
Forward yield666666.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$8.275235618773884e+34M$56.8K
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$8.275075881065991e+34M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GLFN vs MRK ($10,000, DRIP)

YearGLFN PortfolioGLFN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,206$366.19+$66.67MGLFN
2$415,506,651,117$415,435,306,334.37$12,650$502.35+$415506.64MGLFN
3$2,419,908,598,386,268$2,419,464,006,269,573.00$14,407$694.19+$2419908598.37MGLFN
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$16,585$967.82+$13171697643084.44MGLFN
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$19,342$1,363.89+$67004927492790120.00MGLFN
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$22,913$1,947.19+$318562277003514871808.00MGLFN
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$27,662$2,823.89+$1.415484168853553e+24MGLFN
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$34,159$4,173.35+$5.878130573362507e+27MGLFN
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$43,337$6,308.80+$2.2813793009840744e+31MGLFN
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$56,776$9,798.13+$8.275235618773884e+34MGLFN

GLFN vs MRK: Complete Analysis 2026

GLFNStock

McHenry Metals Golf Corp. engages in the design, development, and marketing of golf clubs. The company's TourPure product line includes five drivers and six fairway woods. Left-handed versions of the driver were designed in two models and shorter shafts and smaller grips were made available for ladies clubs. The TourPure driver's proprietary Tungsten Power Ring produces launch angles and reduces backspin, resulting in roll and distance down the fairway. Its distribution channels include the industry's retail channel of off-course golf specialty stores and on-course golf shops; on-course product demonstrations; direct response marketing through television infomercials; direct response catalogs; outbound telemarketing; e-commerce through Internet 'e-tailers' and the company's proprietary Web site (www.mchenrymetals.com); and distributors with domestic and international accounts. Its competitors include Callaway Golf Company, TaylorMade-adidas Golf Company, Acushnet, Ping, Wilson, and Spalding. The company is based in Carlsbad, California.

Full GLFN Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GLFN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLFN vs SCHDGLFN vs JEPIGLFN vs OGLFN vs KOGLFN vs MAINGLFN vs JNJGLFN vs ABBVGLFN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.